Insider Trading activities of Biomarin Pharmaceutical Inc insiders. , Part 8

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $391,764,550.
The total value of stock option exercises since 2005 is $108,663,205.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN) , Part 8
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-01-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 36.09 541,410
2008-01-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 6.46 96,900
2007-12-21 Wood Mark (VP, Human Resources) Sale 6,114 36.08 220,562
2007-12-21 Wood Mark (VP, Human Resources) Option Ex 6,114 12.19 74,499
2007-12-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 35.53 532,980
2007-12-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 6.46 96,900
2007-11-21 Wood Mark (VP, Human Resources) Sale 2,365 25.82 61,052
2007-11-21 Wood Mark (VP, Human Resources) Option Ex 2,365 11.16 26,383
2007-10-31 Kakkis Emil D (Chief Medical Officer) Buy 2,038 6.92 14,100
2007-10-31 Aselage Steve (SVP, Global Commercial Dev) Buy 2,139 6.92 14,799
2007-10-31 Bienaime Jean Jacques (Chief Executive Officer) Buy 518 6.92 3,584
2007-10-24 Wood Mark (VP, Human Resources) Sale 833 26.00 21,658
2007-10-24 Wood Mark (VP, Human Resources) Option Ex 833 17.54 14,610
2007-10-22 Wood Mark (VP, Human Resources) Sale 1,532 25.30 38,761
2007-10-22 Wood Mark (VP, Human Resources) Option Ex 1,532 9.56 14,645
2007-10-11 Davis George Eric (VP, General Counsel) Sale 5,000 27.34 136,700
2007-10-11 Davis George Eric (VP, General Counsel) Option Ex 5,000 8.05 40,250
2007-10-08 Wood Mark (VP, Human Resources) Sale 8,333 26.00 216,658
2007-10-08 Wood Mark (VP, Human Resources) Option Ex 8,333 17.54 146,160
2007-10-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,380 26.00 321,880
2007-10-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 12,380 8.10 100,278
2007-10-01 Davis George Eric (VP, General Counsel) Sale 5,000 25.10 125,500
2007-10-01 Davis George Eric (VP, General Counsel) Option Ex 5,000 6.13 30,650
2007-10-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 25.07 313,400
2007-10-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 5.07 63,312
2007-10-01 Aselage Steve (SVP, Global Commercial Dev) Sale 5,000 25.09 125,450
2007-10-01 Aselage Steve (SVP, Global Commercial Dev) Option Ex 5,000 7.16 35,800
2007-10-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 793 25.10 19,904
2007-10-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 793 6.46 5,122
2007-09-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 19,207 25.00 480,175
2007-09-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 19,207 6.46 124,077
2007-09-26 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,500 24.50 306,250
2007-09-26 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 12,500 8.10 101,250
2007-09-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 24.00 240,000
2007-09-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 6.46 64,600
2007-09-21 Wood Mark (VP, Human Resources) Sale 5,906 23.24 137,261
2007-09-21 Wood Mark (VP, Human Resources) Option Ex 5,906 9.56 56,461
2007-09-19 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 23.00 230,000
2007-09-19 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 6.46 64,600
2007-09-14 Baffi Robert (SVP, Technical Operations) Sale 90,000 22.57 2,026,593
2007-09-14 Baffi Robert (SVP, Technical Operations) Option Ex 90,000 6.13 551,700
2007-09-14 Aselage Steve (SVP, Global Commercial Dev.) Sale 10,000 22.40 224,000
2007-09-14 Aselage Steve (SVP, Global Commercial Dev.) Option Ex 10,000 7.16 71,600
2007-09-06 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 13,536 22.50 304,560
2007-09-06 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 13,536 8.10 109,641
2007-08-17 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 20,000 20.28 405,640
2007-08-17 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 20,000 6.35 126,920
2007-08-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 21.00 210,000
2007-08-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 6.46 64,600
2007-08-15 Davis George Eric (VP, General Counsel) Sale 4,000 20.26 81,040
2007-08-15 Davis George Eric (VP, General Counsel) Option Ex 4,000 6.13 24,520
2007-08-10 Wood Mark (VP, Human Resources) Sale 2,633 21.08 55,503
2007-08-10 Wood Mark (VP, Human Resources) Option Ex 2,633 8.08 21,274
2007-08-10 Aselage Steve (SVP, Global Commercial Dev) Sale 20,000 20.29 405,880
2007-08-10 Aselage Steve (SVP, Global Commercial Dev) Option Ex 20,000 7.16 143,200
2007-08-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 35,886 20.20 725,076
2007-08-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 35,886 6.46 231,823
2007-08-10 Lewis Alan (Director) Sale 20,000 20.13 402,680
2007-08-10 Lewis Alan (Director) Option Ex 30,000 7.72 231,600
2007-08-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 12,500 21.00 262,500
2007-08-08 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 12,500 8.10 101,250
2007-08-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 18.02 36,048
2007-07-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 18.28 36,568
2007-07-02 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 18.18 227,250
2007-07-02 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 4.00 50,000
2007-06-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,500 17.65 44,125
2007-06-07 Wood Mark (VP, Human Resources) Sale 1,045 17.54 18,332
2007-06-07 Wood Mark (VP, Human Resources) Option Ex 1,045 8.08 8,443
2007-06-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,500 18.39 45,975
2007-06-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 18.33 183,299
2007-06-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 6.46 64,600
2007-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 18.56 37,120
2007-05-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 16.79 251,790
2007-05-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 6.46 96,900
2007-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 16.43 24,646
2007-04-30 Davis George Eric (VP, General Counsel) Buy 2,607 5.18 13,517
2007-04-30 Baffi Robert (SVP, Technical Operations) Buy 2,684 5.18 13,916
2007-04-30 Kakkis Emil D (Chief Medical Officer) Buy 2,982 5.18 15,461
2007-04-30 Aselage Steve (SVP, Global Commercial Dev) Buy 2,066 6.92 14,294
2007-04-30 Bienaime Jean Jacques (Chief Executive Officer) Buy 2,553 6.92 17,664
2007-04-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 6,500 17.86 116,116
2007-04-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 6.46 32,300
2007-04-02 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 17.30 216,237
2007-04-02 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 4.00 50,000
2007-03-07 Klein Joseph Iii (Director) Sale 12,000 16.37 196,464
2007-03-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 16.48 24,724
2007-02-22 Davis George Eric (VP, General Counsel) Sale 13,000 18.38 238,940
2007-02-22 Davis George Eric (VP, General Counsel) Option Ex 13,000 6.13 79,690
2007-02-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 18.40 18,400
2007-02-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 13,000 16.96 220,480
2007-02-14 Aselage Steve (SVP, Global Commercial Ops) Sale 15,000 20.00 300,000
2007-02-14 Aselage Steve (SVP, Global Commercial Ops) Option Ex 15,000 7.16 107,400
2007-01-03 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 16.30 203,700
2007-01-03 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 4.00 50,000
2006-12-12 Lapalme Pierre (Director) Buy 2,100 17.88 37,554
2006-12-06 Cooper Jeffrey H (Chief Financial Officer) Sale 14,500 18.00 261,000
2006-12-06 Cooper Jeffrey H (Chief Financial Officer) Option Ex 14,500 8.10 117,450
2006-11-29 Aselage Steve (SVP, Global Commercial Ops) Sale 5,000 17.23 86,150
2006-11-29 Aselage Steve (SVP, Global Commercial Ops) Option Ex 5,000 7.16 35,800
2006-11-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 15.92 198,975
2006-11-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 4.00 50,000
2006-10-31 Baffi Robert (SVP, Technical Operations) Buy 3,894 3.43 13,371
2006-10-31 Kakkis Emil D (Chief Medical Officer) Buy 4,368 3.43 14,999
2006-10-31 Aselage Steve (SVP, Global Commercial Ops) Buy 1,870 6.92 12,938
2006-10-31 Bienaime Jean Jacques (Chief Executive Officer) Buy 2,761 6.92 19,103
2006-08-29 Cooper Jeffrey H (VP, Chief Financial Officer) Sale 26,000 16.00 416,000
2006-08-29 Cooper Jeffrey H (VP, Chief Financial Officer) Option Ex 26,000 7.12 184,990
2006-08-09 Klein Joseph Iii (Director) Sale 40,000 15.52 620,640
2006-08-09 Klein Joseph Iii (Director) Option Ex 60,000 7.72 463,200
2006-08-07 Lapalme Pierre (Director) Buy 1,000 15.35 15,350
2006-08-01 Swiedler Stuart J (SVP, Clinical Affairs) Sale 12,500 14.34 179,187
2006-08-01 Swiedler Stuart J (SVP, Clinical Affairs) Option Ex 12,500 4.00 50,000
2006-08-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 14.50 21,750
2006-07-19 Heron Elaine J (Director) Option Ex 20,000 4.72 94,400
2006-07-03 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 14.44 21,658
2006-06-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 13.05 19,575
2006-05-18 Bienaime Jean Jacques (Chief Executive Officer) Buy 2,000 12.00 24,000
2006-05-08 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,000 12.78 12,778
2006-05-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 12.59 18,879
2006-04-03 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 13.34 20,010
2006-03-16 Cooper Jeffrey H (Chief Financial Officer) Sale 12,500 14.85 185,625
2006-03-16 Cooper Jeffrey H (Chief Financial Officer) Option Ex 12,500 8.10 101,250
2006-03-01 Cooper Jeffrey H (Chief Financial Officer) Sale 15,500 13.25 205,375
2006-03-01 Cooper Jeffrey H (Chief Financial Officer) Option Ex 15,500 5.64 87,420
2006-03-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 12.99 19,489
2006-02-27 Cooper Jeffrey H (Chief Financial Officer) Sale 1,000 13.25 13,250
2006-02-27 Cooper Jeffrey H (Chief Financial Officer) Option Ex 1,000 5.15 5,150
2006-02-27 Lapalme Pierre (Director) Buy 3,500 12.98 45,440
2006-02-24 Sager Erich (Director) Sale 11,500 12.64 145,360
2006-02-24 Sager Erich (Director) Option Ex 11,500 7.00 80,500
2006-02-22 Sager Erich (Director) Sale 1,000 12.20 12,200
2006-02-22 Sager Erich (Director) Option Ex 1,000 7.00 7,000
2006-02-01 Swiedler Stuart J (SVP, Clinical Affair) Sale 10,000 11.55 115,470
2006-02-01 Swiedler Stuart J (SVP, Clinical Affair) Option Ex 10,000 4.00 40,000
2006-02-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 11.67 17,500
2006-01-27 Sager Erich (Director) Sale 2,500 12.20 30,500
2006-01-27 Sager Erich (Director) Option Ex 2,500 7.00 17,500
2006-01-04 Kakkis Emil D (Chief Medical Officer) Option Ex 50,000 4.00 200,000
2006-01-03 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 10.79 16,177
2005-12-12 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,000 10.21 10,208
2005-12-05 Sager Erich (Director) Sale 7,500 10.70 80,257
2005-12-01 Sager Erich (Director) Sale 22,500 10.42 234,450
2005-12-01 Starr Christopher M (SVP, Chief Scientifi) Sale 10,571 10.00 105,710
2005-12-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 9.96 14,937
2005-11-21 Swiedler Stuart J (SVP, Clinical Affair) Sale 30,000 10.00 300,000
2005-11-21 Starr Christopher M (SVP, Chief Scientifi) Sale 10,571 10.00 105,710
2005-11-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 8.37 12,554
2005-10-12 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,000 7.00 7,000
2005-10-06 Bienaime Jean Jacques (Chief Executive Officer) Buy 500 8.00 4,000
2005-10-03 Bienaime Jean Jacques (Chief Executive Officer) Buy 1,500 8.51 12,765
2005-09-01 Bienaime Jean Jacques (Chief Executive Officer) Buy 4,500 8.57 38,587

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.